Under the terms of the agreement, Yabao will exclusively own rights to commercialize certain Salus Pharma-developed products outside the U.S. and to manufacture for worldwide markets, while Salus
The round was co-led by Pfizer Venture Investments and Roche Venture Fund, and brings the combined total investment in the company to $59 million. The round also included
The documentation is being prepared to create the JV as a legal entity named OncBioMune Mexico S.A. de C.V. ("OncBioMune Mexico"). It has been agreed that Dr. Jonathan
Under the terms of the agreement, Evotec will manage Pierre Fabre’s compound collection (individual compounds and collection plates) out of its state-of-the-art compound management facility in Toulouse, France.
DYANAVEL XR is now available in U.S. pharmacies by prescription only. DYANAVEL XR is a federally controlled substance (CII) because it can be abused or lead to dependence.
The SEPCELL project is a randomized, double-blind, placebo-controlled, Phase Ib/IIa study in severe sepsis secondary to severe CAP (sCAP). Subjects in the trial must have sCAP requiring mechanical
The new 4500m2 facility will be opened by UK Life Sciences Minister George Freeman MP and GSK Chief Executive Officer Sir Andrew Witty. It is the latest expansion
LAT Pharma brings a promising new therapeutic opportunity to NanoAntibiotics. Earlier this year LAT Pharma met with the FDA to discuss a submission for a novel therapy to
The collaboration provides for the research, development, and commercialization of antibody-based cancer therapeutics against two novel Compugen-discovered immune checkpoint regulators, CGEN-15001T and CGEN-15022. In December 2015, the Company
This will expand the original partnership agreement signed on April 2015, from four to five products, and adds a separate agreement which allows Vitruvias to buy in to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.